Baxter International INC (BAX) — 10-Q Filings

10-Q Filings (6)

• Baxter Swings to Q3 Loss Amid Kidney Care Divestiture Adjustments — Nov 4, 2025 Risk: medium
  Baxter International Inc. reported a net loss attributable to stockholders of $46 million for the three months ended September 30, 2025, a significant decline f
• Baxter Swings to $1.05B Loss on BioPharma Unit Impairment — Aug 5, 2025 Risk: high
  Baxter International Inc. reported a net loss of $1.049 billion for the six months ended June 30, 2025, a significant decline from a net income of $345 million
• Baxter International Inc. Files 10-Q for Q1 2025 — May 6, 2025 Risk: low
  Baxter International Inc. reported its first quarter 2025 results, ending March 31, 2025. The company's filing details its financial position and operational hi
• Baxter International Inc. Files Q3 2024 10-Q Report — Nov 12, 2024 Risk: low
  Baxter International Inc. reported its third-quarter results for the period ending September 30, 2024. The company's financial performance for the quarter and y
• Baxter International Inc. Files 10-Q for Q2 2024 — Aug 6, 2024 Risk: low
  Baxter International Inc. reported its second quarter 2024 results, ending June 30, 2024. The company's financial performance for the period and its ongoing ope
• Baxter International Inc. Files 10-Q for Period Ending March 31, 2024 — May 2, 2024 Risk: low
  BAXTER INTERNATIONAL INC (BAX) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. Baxter International Inc. filed its quarterly report (10-Q) for the

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX